| BYDUREON AMYLIN PHARMACEUTICALS LLC
1384969 26 Feb 2008 | on 25 May 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely metabolic syndrome, endocrine conditions and disorders, namely glucoregulatory disorders, impaired glucose tolerance, insulin resistance, diabetes, diabetic complications, obesity. | | | BYDUREON WYSP AMYLIN PHARMACEUTICALS LLC
1607608 20 Dec 2012 | on 13 Jul 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely metabolic syndrome, polycystic ovary syndrome, Syndrome X, endocrine conditions and disorders, namely glucoregulatory disorders, impaired glucose tolerance, insulin resistance, diabetic complications, obesity, and diabetes; pre-filled medical injection pens for drug delivery filled with pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely metabolic syndrome, polycystic ovary syndrome, Syndrome X, endocrine conditions and disorders, namely glucoregulatory disorders, impaired glucose tolerance, insulin resistance, diabetic complications, obesity, and diabetes | | | BYDUREON SILQ AMYLIN PHARMACEUTICALS LLC
1607607 20 Dec 2012 | on 13 Jul 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely metabolic syndrome, polycystic ovary syndrome, Syndrome X, endocrine conditions and disorders, namely glucoregulatory disorders, impaired glucose tolerance, insulin resistance, diabetic complications, obesity, and diabetes; pre-filled medical injection pens for drug delivery filled with pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely metabolic syndrome, polycystic ovary syndrome, Syndrome X, endocrine conditions and disorders, namely glucoregulatory disorders, impaired glucose tolerance, insulin resistance, diabetic complications, obesity, and diabetes | | | BYDUREON WHISPEN AMYLIN PHARMACEUTICALS LLC
1607613 20 Dec 2012 | on 13 Jan 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely metabolic syndrome, polycystic ovary syndrome, Syndrome X, endocrine conditions and disorders, namely glucoregulatory disorders, impaired glucose tolerance, insulin resistance, diabetic complications, obesity, and diabetes; pre-filled medical injection pens for drug delivery filled with pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely metabolic syndrome, polycystic ovary syndrome, Syndrome X, endocrine conditions and disorders, namely glucoregulatory disorders, impaired glucose tolerance, insulin resistance, diabetic complications, obesity, and diabetes | | | BYDUREON XUSPEN AMYLIN PHARMACEUTICALS LLC
1607606 20 Dec 2012 | on 13 Jan 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, namely pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely metabolic syndrome, polycystic ovary syndrome, Syndrome X, endocrine conditions and disorders, namely glucoregulatory disorders, impaired glucose tolerance, insulin resistance, diabetic complications, obesity, and diabetes; pre-filled medical injection pens for drug delivery filled with pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, namely metabolic syndrome, polycystic ovary syndrome, Syndrome X, endocrine conditions and disorders, namely glucoregulatory disorders, impaired glucose tolerance, insulin resistance, diabetic complications, obesity, and diabetes | | 
